Squamous cell carcinoma metastatic to the neck from an unknown head and neck primary site

• Published in: American journal of otolaryngology Vol. 22; no. 4; pp. 261 - 267
• Main Authors: Mendenhall, William M., Mancuso, Anthony A., Amdur, Robert J., Stringer, Scott P., Villaret, Douglas B., Cassisi, Nicholas J.
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 01-07-2001; Elsevier
• Subjects: Biological and medical sciences; Biopsy, Needle; Carcinoma, Squamous Cell - diagnosis; Carcinoma, Squamous Cell - radiotherapy; Carcinoma, Squamous Cell - secondary; Head and Neck Neoplasms - diagnosis; Head and Neck Neoplasms - radiotherapy; Head and Neck Neoplasms - secondary; Humans; Lymph Nodes - pathology; Magnetic Resonance Imaging; Medical sciences; Neoplasms, Unknown Primary - diagnosis; Neoplasms, Unknown Primary - radiotherapy; Otorhinolaryngology (head neck, general aspects and miscellaneous); Otorhinolaryngology. Stomatology; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Tumors; Radionuclide study; Panendoscopy; Amygdala; Incidence; Head and neck; ENT disease; Diagnosis; Endoscopy; Localization; Human; Squamous cell carcinoma; Radiodiagnosis; Treatment efficiency; Exploration; Malignant tumor; Tongue base; Anatomy; Nuclear magnetic resonance imaging; Photon; Five year survival; Treatment; Medical imagery; Metastatic; Computerized axial tomography; Mucosa disease; Technique; Comparative study; Bibliographic review; Positron; Emission tomography
• ISSN: 0196-0709; 1532-818X
• DOI: 10.1053/ajot.2001.24820

Squamous cell carcinoma metastatic to the neck from an unknown head and neck primary site is relatively uncommon and presents a challenging diagnostic and therapeutic dilemma. Diagnostic evaluation includes fine-needle aspiration of the neck mass, chest roentgenography, computed tomography, and/or magnetic resonance imaging of the head and neck, followed by panendoscopy and biopsies. The primary tumor will be detected in approximately 40% of patients; approximately 80% of cancers are located in the base of the tongue or tonsillar fossa. Management options include treatment of the neck alone or both sides of the neck and the potential head and neck primary sites. The latter approach is associated with better long-term control above the clavicles. The 5-year survival rate is approximately 50% after treatment and is influenced by the extent of neck disease. In this article, we review the pertinent literature. (Am J Otolaryngol 2001;22:261-267. Copyright © 2001 by W.B. Saunders Company)